Sensitive ASX Announcement

FDA Grants Orphan Drug Designation for PTX-200 in AML

Published: 01/05/17, 08:50am (AEST)2 pages
Prescient Therapeutics Limited
PTX:ASXHealthcare

Recent PTX Announcements

Price Sensitive only